Balloon Dilation Extended Airway Relief in GPA Patients

A small study found that paclitaxel-coated balloons doubled the time between procedures for patients with GPA-related airway narrowing.

Updated on Sept. 22, 2026 in Asthma

A close-up view of a medical balloon catheter inside a clear, synthetic airway model in a sterile laboratory setting.
A study found that paclitaxel-coated balloon dilation can significantly extend the time between required airway interventions for patients suffering from GPA-related stenosis. AI Illustration. Upload story photo >

Live Poll

Is now a good time to pursue new, minimally invasive medical procedures for chronic conditions?

Researchers evaluated the use of paclitaxel-coated balloon dilation to treat airway stenosis in patients with granulomatosis with polyangiitis (GPA). The study observed that patients experienced a significant increase in the time between necessary airway interventions following the treatment, which concluded in December 2025.

Why it matters

Patients with GPA often suffer from recurrent airway narrowing that necessitates frequent, repeated bronchoscopy interventions to breathe comfortably. This treatment approach aims to provide longer-lasting relief, though the findings remain preliminary.

In a retrospective study of six adult patients with GPA, researchers compared interprocedure intervals before and after paclitaxel-coated balloon dilation. The treatment resulted in a median interval increase to 3.45 months, compared to 1.61 months prior to the intervention.

The details

The procedure functions by inflating a balloon, with a median diameter of 12 mm, inside the narrowed airway for a sustained duration of two minutes. The balloon is coated with paclitaxel, a medication that limits tissue growth and helps maintain airway patency over a longer period. No procedural or delayed complications were reported during the study duration.

Timeline

  1. December 2024 marked the start of patient data collection for the study.

  2. December 2025 marked the end of patient data collection for the study.

Health Landscape

Current standard care for GPA-related airway stenosis relies on frequent, repeated bronchoscopic interventions to clear obstructions. This research explores whether drug-eluting technology can reduce the high burden of care typically required for these patients.

If you or a loved one are managing GPA-related airway narrowing, it is worth discussing these findings with a pulmonologist to understand if new interventional options might fit your care plan. Always coordinate with your specialist regarding the frequency and type of procedures required for your specific condition.

The takeaway

While this intervention shows promise in extending the time between airway procedures for patients with GPA, the research is preliminary and limited to a very small group. Patients should consult their care team about whether their treatment schedule aligns with current evidence-based approaches to airway maintenance.

Further reading

Learn more about the management of complex airway conditions in our Asthma section.

Source note: This article includes information reported by Medscape.

Live Poll

Is now a good time to pursue new, minimally invasive medical procedures for chronic conditions?